Filing Analysis
Securities Offering
Filed Apr 16, 2026
HIGH
HeartBeam, Inc. closed a $10.0 million underwritten public offering of 12.5 million shares of common stock at a price of $0.80 per share. The company intends to use the proceeds to commercialize its FDA-cleared 12-lead synthesized ECG system and advance its AI and heart attack detection initiatives.
Red Flags
- Significant dilution from the issuance of 12.5 million new shares.
- Issuance of underwriter warrants (5% coverage) creates additional future dilution potential.
- Relatively short lock-up period of 75 days for insiders.
Key Facts
- Offering of 12,500,000 shares of common stock at $0.80 per share.
- Gross proceeds of approximately $10.0 million before expenses.
- Underwriter (Titan Partners Group LLC) granted a 30-day option to purchase up to 1,875,000 additional shares.
- Underwriter received warrants to purchase 5% of the total shares sold, exercisable for five years.
- Company, officers, and directors are subject to a 75-day lock-up period.
- Closing of the offering occurred on April 16, 2026.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.